US Patent Litigations are now available. Check here

Explore Csl Behring Recombinant Facility's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jun 26, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3383894May 6, 2020Improved Media For The Expression Of Recombinant Vitamin K-Dependent Proteins1